Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
Sponsor: Biogipuzkoa Health Research Institute
Summary
In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.
Official title: Ejercicio Físico Durante El Tratamiento De Quimioterapia Como Programa Adyuvante En Pacientes Con Linfoma: Estudio EDONOLA
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2024-10-08
Completion Date
2027-03-30
Last Updated
2025-02-19
Healthy Volunteers
No
Conditions
Interventions
Exercise
The lymphoma unit of the Donostia University Hospital (HUD) is part of the Onkofrail project that analyzes the impact of a physical activity in older cancer patients. The Onkofrail study has included everything type of solid tumors and very diverse treatments, which is a limitation methodology that could condition the analysis of the results. Therefore, the need of proposing a new PE project in a homogeneous population such as that of people with lymphoma, the most prevalent hemopathy in our environment, which has a great survival, but present important adverse effects secondary to treatment systemic.
Locations (3)
Hospital Universitario Araba (HUA)
Vitoria - Gateiz, Araba, Spain
Hospital Universitario Galdakao (HUG)
Galdakao, Bizkaia, Spain
Hospital Universitario Donostia (HUD)
San Sebastián, Guipuzcoa, Spain